1. Home
  2. ACCL vs RNXT Comparison

ACCL vs RNXT Comparison

Compare ACCL & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACCL

Acco Group Holdings Limited Ordinary Shares

N/A

Current Price

$1.52

Market Cap

20.2M

ML Signal

N/A

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.79

Market Cap

37.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACCL
RNXT
Founded
2009
2012
Country
Hong Kong
United States
Employees
22
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.2M
37.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ACCL
RNXT
Price
$1.52
$0.79
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.00
AVG Volume (30 Days)
77.3K
191.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
59.60
EPS
N/A
N/A
Revenue
N/A
$43,000.00
Revenue This Year
N/A
$2,995.35
Revenue Next Year
N/A
$219.61
P/E Ratio
$17.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.23
$0.70
52 Week High
$5.00
$1.45

Technical Indicators

Market Signals
Indicator
ACCL
RNXT
Relative Strength Index (RSI) 47.45 33.44
Support Level $1.29 $0.70
Resistance Level $1.69 $1.07
Average True Range (ATR) 0.13 0.07
MACD 0.07 -0.01
Stochastic Oscillator 49.08 7.73

Price Performance

Historical Comparison
ACCL
RNXT

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: